Millipore said that itss BioPharma Services unit is the first CRO dedicated to large molecule bioanalytical work. The unit arose from Millipore’s acquisition in August, 2009 of BioAnaLab, an Oxford University spin-out, a CRO which is into the analysis of biological therapeutics, such as antibodies, vaccines, recombinant proteins, cytokines and growth hormones.
Geoff Hale, managing director of BioAnaLab, said: “The new laboratory provides us with space to continue our growth as we expand the range of services we provide.”
Craig Morley, global managing director of BioPharma services at Millipore, said: “The new facility complements the facilities at our St Charles site.”